Portfolio company
Faeth Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops precision nutrition solutions and metabolic therapies to treat cancer patients by combining dietary control with targeted drugs and digital tools.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Meliora Therapeutics
This company develops a machine-learning platform to identify drug mechanisms and create precision oncology treatments for pharmaceutical partners and cancer patients.
Bactheravax
This company develops therapeutic vaccines targeting tumour-associated bacteria to improve treatment sensitivity and immune responses for patients with colorectal and other cancers.
Waypoint Bio
This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.
Cold Start Therapeutics
This company develops multimeric fusion proteins using machine learning to target cancer cells and engage immune cells for patients with oncological diseases.
DualTPharma
This company develops bacteria-based drug delivery systems to transport immunotherapies into solid tumours for cancer patients.
Mika
This company develops a digital companion app that provides personalised support, symptom tracking and psycho-oncological therapy for cancer patients and their caregivers.
Neobe
The company develops engineered microbial biotherapeutics designed to disrupt the microenvironment of solid tumours for cancer patients receiving immunotherapy.
Una Health
This company develops personalized digital therapy software and biosensor technology for individuals with type 2 diabetes to manage and reverse metabolic dysfunction.
